15 Stocks Moving In Tuesday's After-Hours Session

Gainers

• Axcelis Technologies ACLS shares are trading higher after the company raised Q4 guidance and reported a $100 million buyback.
• DermTech DMTK shares are trading higher after the company announced that non-invasive genomic patch testing for melanoma has received a recommendation from the National Comprehensive Cancer Network.
• Farmer Bros Co FARM shares are trading higher after the company reported a strategic partnership with High Brew Coffee.
• EXFO EXFO shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
• Ally Financial ALLY shares are trading higher after the company announced a buyback of up to $1.6 billion.
• Bausch Health Companies BHC shares are trading higher after the company issued Q4 sales guidance of greater than $2.2 billion, compared to the $2.12 billion estimate.
• Matrix Service Co MRTX shares are trading higher after the company announced Chart Industries signed a Memorandum of Understanding with the company for the development of standardized hydrogen solutions in North America.
• Neuronetics STIM shares are trading higher after the company issued Q4 2020 revenue guidance above estimates.
• Flexible Solutions International FSI shares are trading higher after the company reported Q4 sales results were up 49% year over year.
• Timber Pharmaceuticals TMBR shares are trading higher after the company today announced it received Orphan Drug Designation from the FDA for TMB-003 for the treatment of Systemic Sclerosis. NOTE: The news was reported via FDA website on Monday.

Losers

• Affimed AFMD shares are trading lower after the company announced a common stock offering. No terms were disclosed.
• Repay RPAY shares are trading lower after the company announced a $130 million share common stock offering.
• Urban Outfitters URBN shares are trading lower after the company reported 2020 holiday sales decreased 8.4% year over year.
• Party City PRTY shares are trading lower after the company issued Q4 sales guidance below estimates and brand comps down in mid-single digit range.
• Provention Bio PRVB shares are trading lower after the company announced a proposed offering of 6 million shares of common stock.